We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Guardant Health
GH
$23B
| $76.3M | 0.14% |
1,465,438
+615,429
| +72% | +$27.5M |
|
177
Abbott
ABT
$194B
| $76.1M | 0.14% |
559,854
-98,398
| -15% | -$13M |
|
178
DraftKings
DKNG
$12.2B
| $75.3M | 0.14% |
1,755,383
-101,817
| -5% | -$3.65M |
|
179
Trip.com Group
TCOM
$28.1B
| $74.7M | 0.14% |
1,273,369
+398,470
| +46% | +$23.9M |
|
180
Ultragenyx Pharmaceutical
RARE
$2.57B
| $74.5M | 0.14% |
2,049,501
-5,699
| -0.3% | -$205K |
|
|
ATYR
181
aTyr Pharma
ATYR
$54.8M
| $74.4M | 0.14% |
14,666,600
| – | – |
|
182
Wintrust Financial
WTFC
$10.3B
| $74.1M | 0.14% |
597,769
-171,755
| -22% | -$19.7M |
|
183
Agnico Eagle Mines
AEM
$109B
| $73.3M | 0.14% |
616,728
-232
| -0% | -$26.9K |
|
184
Intercontinental Exchange
ICE
$91.1B
| $73M | 0.14% |
397,693
-11,440
| -3% | -$1.97M |
|
185
Dollar Tree
DLTR
$24.6B
| $72.9M | 0.14% |
735,915
-6,961
| -0.9% | -$601K |
|
186
Mastercard
MA
$518B
| $72.8M | 0.14% |
129,537
-2,227
| -2% | -$1.23M |
|
187
Baidu
BIDU
$32.8B
| $72.5M | 0.14% |
845,595
-272,830
| -24% | -$23.5M |
|
188
Chipotle Mexican Grill
CMG
$46.9B
| $72M | 0.14% |
1,282,451
-63,693
| -5% | -$3.24M |
|
189
Procter & Gamble
PG
$334B
| $71.7M | 0.14% |
450,347
-11,292
| -2% | -$1.84M |
|
190
Fox Class A
FOXA
$28.8B
| $71.7M | 0.14% |
1,280,317
+24,726
| +2% | +$1.3M |
|
191
Jackson Financial
JXN
$9.04B
| $71.3M | 0.13% |
802,941
-134,631
| -14% | -$10.9M |
|
192
Canadian Imperial Bank of Commerce
CM
$104B
| $71.2M | 0.13% |
1,005,916
+17,517
| +2% | +$1.13M |
|
193
Q2 Holdings
QTWO
$4.11B
| $69.9M | 0.13% |
747,145
+207
| +0% | +$17.5K |
|
194
Reinsurance Group of America
RGA
$16.1B
| $69.2M | 0.13% |
349,111
-93,131
| -21% | -$18.2M |
|
195
O'Reilly Automotive
ORLY
$71.1B
| $68.8M | 0.13% |
763,385
-47,410
| -6% | -$4.32M |
|
|
QXO
196
QXO Inc
QXO
$14.6B
| $68.5M | 0.13% |
3,178,100
| – | – |
|
197
Diageo
DEO
$51.4B
| $68.3M | 0.13% |
677,669
+46,196
| +7% | +$5.01M |
|
198
argenx
ARGX
$65.9B
| $68.2M | 0.13% |
123,659
+14,714
| +14% | +$8.54M |
|
199
Wabtec
WAB
$50.3B
| $68M | 0.13% |
324,735
-1,182
| -0.4% | -$227K |
|
200
Planet Fitness
PLNT
$3.96B
| $67.9M | 0.13% |
622,392
-37,207
| -6% | -$3.73M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.